{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T16:57:19Z","timestamp":1772384239848,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ministry of science, Technological Development and Innovations of the Republic of Serbia","award":["451-03-47\/2023-01\/200178"],"award-info":[{"award-number":["451-03-47\/2023-01\/200178"]}]},{"name":"Ministry of science, Technological Development and Innovations of the Republic of Serbia","award":["451-03-47\/2023-01\/200178"],"award-info":[{"award-number":["451-03-47\/2023-01\/200178"]}]},{"name":"Ministry of science, Technological Development and Innovations of the Republic of Serbia","award":["451-03-47\/2023-01\/200178"],"award-info":[{"award-number":["451-03-47\/2023-01\/200178"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s12035-024-04183-8","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T04:01:43Z","timestamp":1713844903000},"page":"9539-9547","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between Cytotoxic T-Lymphocyte-Associated Antigen 4 (CTLA-4) Locus and Early-Onset Anti-acetylcholine Receptor-Positive Myasthenia Gravis in Serbian Patients"],"prefix":"10.1007","volume":"61","author":[{"given":"Ivana","family":"Djordjevic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nemanja","family":"Garai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stojan","family":"Peric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena","family":"Karanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jovan","family":"Pesovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milos","family":"Brkusanin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dragana","family":"Lavrnic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Slobodan","family":"Apostolski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dusanka","family":"Savic-Pavicevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Basta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,23]]},"reference":[{"key":"4183_CR1","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fimmu.2020.00212","volume":"11","author":"K Lazaridis","year":"2020","unstructured":"Lazaridis K, Tzartos SJ (2020) Autoantibody specificities in myasthenia gravis; implications for improved diagnostics and therapeutics. Front Immunol 11:212. https:\/\/doi.org\/10.3389\/fimmu.2020.00212","journal-title":"Front Immunol"},{"issue":"1","key":"4183_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.25122\/jml-2020-0145","volume":"14","author":"AM Bubuioc","year":"2021","unstructured":"Bubuioc AM, Kudebayeva A, Turuspekova S, Lisnic V, Leone MA (2021) The epidemiology of myasthenia gravis. J Med Life 14(1):7\u201316. https:\/\/doi.org\/10.25122\/jml-2020-0145","journal-title":"J Med Life"},{"issue":"3","key":"4183_CR3","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1159\/000342777","volume":"40","author":"D Lavrnic","year":"2013","unstructured":"Lavrnic D, Basta I, Rakocevic-Stojanovic V et al (2013) Epidemiological study of adult-onset myasthenia gravis in the area of Belgrade (Serbia) in the period 1979\u20132008. Neuroepidemiology 40(3):190\u2013194. https:\/\/doi.org\/10.1159\/000342777","journal-title":"Neuroepidemiology"},{"key":"4183_CR4","doi-asserted-by":"publisher","unstructured":"Chia R, Saez-Atienzar S, Murphy N et al (2022) Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study. Proc Nat Acad Sci USt Am 119(5):e2108672119. https:\/\/doi.org\/10.1073\/pnas.2108672119","DOI":"10.1073\/pnas.2108672119"},{"issue":"6","key":"4183_CR5","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/ana.23691","volume":"72","author":"PK Gregersen","year":"2012","unstructured":"Gregersen PK, Kosoy R, Lee AT et al (2012) Risk for myasthenia gravis maps to a (151) Pro\u2013>Ala change in TNIP1 and to human leukocyte antigen-B*08. Ann Neurol 72(6):927\u2013935. https:\/\/doi.org\/10.1002\/ana.23691","journal-title":"Ann Neurol"},{"issue":"4","key":"4183_CR6","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1001\/jamaneurol.2014.4103","volume":"72","author":"AE Renton","year":"2015","unstructured":"Renton AE, Pliner HA, Provenzano C et al (2015) A genome-wide association study of myasthenia gravis. JAMA Neurol 72(4):396\u2013404. https:\/\/doi.org\/10.1001\/jamaneurol.2014.4103","journal-title":"JAMA Neurol"},{"issue":"1","key":"4183_CR7","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2119\/molmed.2015.00232","volume":"21","author":"MF Seldin","year":"2016","unstructured":"Seldin MF, Alkhairy OK, Lee AT et al (2016) Genome-wide association study of late-onset myasthenia gravis: confirmation of TNFRSF11A and identification of ZBTB10 and three distinct HLA associations. Mol Med 21(1):769\u2013781. https:\/\/doi.org\/10.2119\/molmed.2015.00232","journal-title":"Mol Med"},{"issue":"8","key":"4183_CR8","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1136\/jmedgenet-2021-107953","volume":"59","author":"A Topaloudi","year":"2022","unstructured":"Topaloudi A, Zagoriti Z, Flint AC et al (2022) Myasthenia gravis genome-wide association study implicates AGRN as a risk locus. J Med Genet 59(8):801\u2013809. https:\/\/doi.org\/10.1136\/jmedgenet-2021-107953","journal-title":"J Med Genet"},{"issue":"8","key":"4183_CR9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41576-018-0016-z","volume":"19","author":"DJ Schaid","year":"2018","unstructured":"Schaid DJ, Chen W, Larson NB (2018) From genome-wide associations to candidate causal variants by statistical fine-mapping. Nat Rev Genet 19(8):491\u2013504. https:\/\/doi.org\/10.1038\/s41576-018-0016-z","journal-title":"Nat Rev Genet"},{"issue":"1","key":"4183_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1182\/blood-2017-06-741033","volume":"131","author":"B Rowshanravan","year":"2018","unstructured":"Rowshanravan B, Halliday N, Sansom DM (2018) CTLA-4: a moving target in immunotherapy. Blood 131(1):58\u201367. https:\/\/doi.org\/10.1182\/blood-2017-06-741033","journal-title":"Blood"},{"key":"4183_CR11","doi-asserted-by":"publisher","first-page":"106221","DOI":"10.1016\/j.intimp.2020.106221","volume":"80","author":"A Hosseini","year":"2020","unstructured":"Hosseini A, Gharibi T, Marofi F, Babaloo Z, Baradaran B (2020) CTLA-4: From mechanism to autoimmune therapy. Int Immunopharmacol 80:106221. https:\/\/doi.org\/10.1016\/j.intimp.2020.106221","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"4183_CR12","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/nri3108","volume":"11","author":"LS Walker","year":"2011","unstructured":"Walker LS, Sansom DM (2011) The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses. Nat Rev Immunol 11(12):852\u2013863. https:\/\/doi.org\/10.1038\/nri3108","journal-title":"Nat Rev Immunol"},{"key":"4183_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1146\/annurev.immunol.24.021605.090535","volume":"24","author":"WA Teft","year":"2006","unstructured":"Teft WA, Kirchhof MG, Madrenas J (2006) A molecular perspective of CTLA-4 function. Annu Rev Immunol 24:65\u201397. https:\/\/doi.org\/10.1146\/annurev.immunol.24.021605.090535","journal-title":"Annu Rev Immunol"},{"issue":"1\u20132","key":"4183_CR14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/s0165-5728(98)00119-2","volume":"88","author":"D Huang","year":"1998","unstructured":"Huang D, Liu L, Noren K et al (1998) Genetic association of Ctla-4 to myasthenia gravis with thymoma. J Neuroimmunol 88(1\u20132):192\u2013198. https:\/\/doi.org\/10.1016\/s0165-5728(98)00119-2","journal-title":"J Neuroimmunol"},{"issue":"1","key":"4183_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/sj.gene.6363816","volume":"3","author":"XB Wang","year":"2002","unstructured":"Wang XB, Kakoulidou M, Qiu Q et al (2002) CDS1 and promoter single nucleotide polymorphisms of the CTLA-4 gene in human myasthenia gravis. Genes Immun 3(1):46\u201349. https:\/\/doi.org\/10.1038\/sj.gene.6363816","journal-title":"Genes Immun"},{"issue":"4","key":"4183_CR16","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/ana.20577","volume":"58","author":"WY Chuang","year":"2005","unstructured":"Chuang WY, Strobel P, Gold R et al (2005) A CTLA4high genotype is associated with myasthenia gravis in thymoma patients. Ann Neurol 58(4):644\u2013648. https:\/\/doi.org\/10.1002\/ana.20577","journal-title":"Ann Neurol"},{"issue":"1","key":"4183_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1365-2796.2007.01879.x","volume":"263","author":"XB Wang","year":"2008","unstructured":"Wang XB, Pirskanen R, Giscombe R, Lefvert AK (2008) Two SNPs in the promoter region of the CTLA-4 gene affect binding of transcription factors and are associated with human myasthenia gravis. J Intern Med 263(1):61\u201369. https:\/\/doi.org\/10.1111\/j.1365-2796.2007.01879.x","journal-title":"J Intern Med"},{"key":"4183_CR18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jaut.2013.12.006","volume":"52","author":"WY Chuang","year":"2014","unstructured":"Chuang WY, Strobel P, Bohlender-Willke AL et al (2014) Late-onset myasthenia gravis - CTLA4(low) genotype association and low-for-age thymic output of naive T cells. J Autoimmun 52:122\u2013129. https:\/\/doi.org\/10.1016\/j.jaut.2013.12.006","journal-title":"J Autoimmun"},{"issue":"4","key":"4183_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1759-7714.2012.00121.x","volume":"3","author":"K Zheng","year":"2012","unstructured":"Zheng K, Zhang J, Zhang P, Guo Y (2012) PTPN22 and CTLA-4 gene polymorphisms in resected thymomas and thymus for myasthenia gravis. Thoracic cancer 3(4):307\u2013312. https:\/\/doi.org\/10.1111\/j.1759-7714.2012.00121.x","journal-title":"Thoracic cancer"},{"issue":"7","key":"4183_CR20","doi-asserted-by":"publisher","first-page":"e101986","DOI":"10.1371\/journal.pone.0101986","volume":"9","author":"L Sun","year":"2014","unstructured":"Sun L, Meng Y, Xie Y et al (2014) CTLA4 variants and haplotype contribute genetic susceptibility to myasthenia gravis in northern Chinese population. PLoS ONE 9(7):e101986. https:\/\/doi.org\/10.1371\/journal.pone.0101986","journal-title":"PLoS ONE"},{"key":"4183_CR21","unstructured":"Kong X WL, Wang J, Shan X et al (2016) Correlation between single nucleotide polymorphisms of multi-loci and multi-genes and myasthenia gravis. Chin J Neurol 12:307\u2013311"},{"issue":"6","key":"4183_CR22","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1007\/s12035-016-0024-y","volume":"54","author":"HF Li","year":"2017","unstructured":"Li HF, Hong Y, Zhang X et al (2017) Gene polymorphisms for both auto-antigen and immune-modulating proteins are associated with the susceptibility of autoimmune myasthenia gravis. Mol Neurobiol 54(6):4771\u20134780. https:\/\/doi.org\/10.1007\/s12035-016-0024-y","journal-title":"Mol Neurobiol"},{"key":"4183_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jocn.2019.08.079","volume":"69","author":"GM Cai","year":"2019","unstructured":"Cai GM, Gao Z, Yue YX et al (2019) Association between CTLA-4 gene polymorphism and myasthenia gravis in a Chinese cohort. J Clin Neurosci: Off J Neurosurg Soc Australas 69:31\u201337. https:\/\/doi.org\/10.1016\/j.jocn.2019.08.079","journal-title":"J Clin Neurosci: Off J Neurosurg Soc Australas"},{"issue":"2","key":"4183_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5808\/gi.2012.10.2.117","volume":"10","author":"EP Hong","year":"2012","unstructured":"Hong EP, Park JW (2012) Sample size and statistical power calculation in genetic association studies. Genomics Informat 10(2):117\u2013122. https:\/\/doi.org\/10.5808\/gi.2012.10.2.117","journal-title":"Genomics Informat"},{"issue":"3","key":"4183_CR25","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/ana.26169","volume":"90","author":"L Handunnetthi","year":"2021","unstructured":"Handunnetthi L, Knezevic B, Kasela S et al (2021) Genomic insights into myasthenia gravis identify distinct immunological mechanisms in early and late onset disease. Ann Neurol 90(3):455\u2013463. https:\/\/doi.org\/10.1002\/ana.26169","journal-title":"Ann Neurol"},{"issue":"1","key":"4183_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00281-021-00902-8","volume":"44","author":"QS Wang","year":"2022","unstructured":"Wang QS, Huang H (2022) Methods for statistical fine-mapping and their applications to auto-immune diseases. Semin Immunopathol 44(1):101\u2013113. https:\/\/doi.org\/10.1007\/s00281-021-00902-8","journal-title":"Semin Immunopathol"},{"issue":"1","key":"4183_CR27","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/s0003-4975(00)01595-2","volume":"70","author":"A Jaretzki","year":"2000","unstructured":"Jaretzki A, Barohn RJ, Ernstoff RM et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task force of the medical scientific advisory board of the myasthenia gravis foundation of america. Ann Thorac Surg 70(1):327\u2013334. https:\/\/doi.org\/10.1016\/s0003-4975(00)01595-2","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"4183_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","volume":"21","author":"JC Barrett","year":"2005","unstructured":"Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263\u2013265. https:\/\/doi.org\/10.1093\/bioinformatics\/bth457","journal-title":"Bioinformatics"},{"key":"4183_CR29","unstructured":"Team RC (2022) R: A language and environment for statistical computing. R Foundation for Statistical Computing. https:\/\/www.r-project.org\/. Accessed 20 Jan 2024"},{"issue":"3","key":"4183_CR30","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559\u2013575. https:\/\/doi.org\/10.1086\/519795","journal-title":"Am J Hum Genet"},{"key":"4183_CR31","unstructured":"Moore C, Jacobson S (2021) Power calculations under genetic model misspecification. Cran.r-project. https:\/\/cran.r-project.org\/web\/packages\/genpwr\/genpwr.pdf. Accessed 20 Jan 2024"},{"issue":"2","key":"4183_CR32","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.immuni.2018.01.007","volume":"48","author":"BV Kumar","year":"2018","unstructured":"Kumar BV, Connors TJ, Farber DL (2018) Human t cell development, localization, and function throughout life. Immunity 48(2):202\u2013213. https:\/\/doi.org\/10.1016\/j.immuni.2018.01.007","journal-title":"Immunity"},{"issue":"5","key":"4183_CR33","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/s1474-4422(09)70063-8","volume":"8","author":"MN Meriggioli","year":"2009","unstructured":"Meriggioli MN, Sanders DB (2009) Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 8(5):475\u2013490. https:\/\/doi.org\/10.1016\/s1474-4422(09)70063-8","journal-title":"Lancet Neurol"},{"issue":"9","key":"4183_CR34","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","volume":"12","author":"A Marx","year":"2013","unstructured":"Marx A, Pfister F, Schalke B, Saruhan-Direskeneli G, Melms A, Strobel P (2013) The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev 12(9):875\u2013884. https:\/\/doi.org\/10.1016\/j.autrev.2013.03.007","journal-title":"Autoimmun Rev"},{"key":"4183_CR35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jneuroim.2008.06.017","volume":"201\u2013202","author":"P Strobel","year":"2008","unstructured":"Strobel P, Moritz R, Leite MI et al (2008) The ageing and myasthenic thymus: a morphometric study validating a standard procedure in the histological workup of thymic specimens. J Neuroimmunol 201\u2013202:64\u201373. https:\/\/doi.org\/10.1016\/j.jneuroim.2008.06.017","journal-title":"J Neuroimmunol"},{"issue":"2","key":"4183_CR36","doi-asserted-by":"publisher","first-page":"369","DOI":"10.17219\/acem\/58802","volume":"25","author":"Z Zdrojewicz","year":"2016","unstructured":"Zdrojewicz Z, Pachura E, Pachura P (2016) The thymus: a forgotten, but very important organ. Adv Clin Exp Med: Off Organ Wroclaw Med Univ 25(2):369\u2013375. https:\/\/doi.org\/10.17219\/acem\/58802","journal-title":"Adv Clin Exp Med: Off Organ Wroclaw Med Univ"},{"issue":"3","key":"4183_CR37","doi-asserted-by":"publisher","first-page":"E221","DOI":"10.1073\/pnas.1208573110","volume":"110","author":"J Verhagen","year":"2013","unstructured":"Verhagen J, Genolet R, Britton GJ et al (2013) CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the TCR repertoire. Proc Natl Acad Sci USA 110(3):E221\u2013E230. https:\/\/doi.org\/10.1073\/pnas.1208573110","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"4183_CR38","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/eji.201445064","volume":"45","author":"H Schaffert","year":"2015","unstructured":"Schaffert H, Pelz A, Saxena A et al (2015) IL-17-producing CD4(+) T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis. Eur J Immunol 45(5):1339\u20131347. https:\/\/doi.org\/10.1002\/eji.201445064","journal-title":"Eur J Immunol"},{"issue":"5","key":"4183_CR39","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.4049\/jimmunol.1501339","volume":"196","author":"Y Cao","year":"2016","unstructured":"Cao Y, Amezquita RA, Kleinstein SH, Stathopoulos P, Nowak RJ, O\u2019Connor KC (2016) Autoreactive T cells from patients with myasthenia gravis are characterized by elevated IL-17, IFN-gamma, and GM-CSF and Diminished IL-10 Production. J Immunol 196(5):2075\u20132084. https:\/\/doi.org\/10.4049\/jimmunol.1501339","journal-title":"J Immunol"},{"key":"4183_CR40","unstructured":"Salam N, Rane S, Das R et al (2013) T cell ageing: effects of age on development, survival & function. Ind J Med Res 138(5):595\u2013608. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/pmc3928693\/"},{"issue":"10","key":"4183_CR41","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/s1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ (2015) Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol 14(10):1023\u20131036. https:\/\/doi.org\/10.1016\/s1474-4422(15)00145-3","journal-title":"Lancet Neurol"},{"issue":"6","key":"4183_CR42","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1111\/ene.14820","volume":"28","author":"R Alvarez-Velasco","year":"2021","unstructured":"Alvarez-Velasco R, Gutierrez-Gutierrez G, Trujillo JC et al (2021) Clinical characteristics and outcomes of thymoma-associated myasthenia gravis. Eur J Neurol 28(6):2083\u20132091. https:\/\/doi.org\/10.1111\/ene.14820","journal-title":"Eur J Neurol"},{"key":"4183_CR43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ajo.2019.04.017","volume":"205","author":"TM Hendricks","year":"2019","unstructured":"Hendricks TM, Bhatti MT, Hodge DO, Chen JJ (2019) Incidence, epidemiology, and transformation of ocular myasthenia gravis: a population-based study. Am J Ophthalmol 205:99\u2013105. https:\/\/doi.org\/10.1016\/j.ajo.2019.04.017","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"4183_CR44","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/ahg.12262","volume":"82","author":"F Li","year":"2018","unstructured":"Li F, Yuan W, Wu X (2018) Association of CTLA-4 polymorphisms with increased risks of myasthenia gravis. Ann Hum Genet 82(6):358\u2013369. https:\/\/doi.org\/10.1111\/ahg.12262","journal-title":"Ann Hum Genet"},{"issue":"7","key":"4183_CR45","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.humimm.2009.03.016","volume":"70","author":"M Fernandez-Mestre","year":"2009","unstructured":"Fernandez-Mestre M, Sanchez K, Balbas O et al (2009) Influence of CTLA-4 gene polymorphism in autoimmune and infectious diseases. Hum Immunol 70(7):532\u2013535. https:\/\/doi.org\/10.1016\/j.humimm.2009.03.016","journal-title":"Hum Immunol"},{"issue":"3","key":"4183_CR46","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nrd.2017.226","volume":"17","author":"SA Dugger","year":"2018","unstructured":"Dugger SA, Platt A, Goldstein DB (2018) Drug development in the era of precision medicine. Nat Rev Drug Discovery 17(3):183\u2013196. https:\/\/doi.org\/10.1038\/nrd.2017.226","journal-title":"Nat Rev Drug Discovery"},{"issue":"49","key":"4183_CR47","doi-asserted-by":"publisher","first-page":"19396","DOI":"10.1073\/pnas.0806855105","volume":"105","author":"F Flores-Borja","year":"2008","unstructured":"Flores-Borja F, Jury EC, Mauri C, Ehrenstein MR (2008) Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc Natl Acad Sci USA 105(49):19396\u201319401. https:\/\/doi.org\/10.1073\/pnas.0806855105","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"4183_CR48","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.2337\/db11-0130","volume":"60","author":"KD Gerold","year":"2011","unstructured":"Gerold KD, Zheng P, Rainbow DB, Zernecke A, Wicker LS, Kissler S (2011) The soluble CTLA-4 splice variant protects from type 1 diabetes and potentiates regulatory T-cell function. Diabetes 60(7):1955\u20131963. https:\/\/doi.org\/10.2337\/db11-0130","journal-title":"Diabetes"},{"key":"4183_CR49","doi-asserted-by":"publisher","unstructured":"Derakhshani A, Asadzadeh Z, Safarpour H et al (2021) Regulation of CTLA-4 and PD-L1 expression in relapsing-remitting multiple sclerosis patients after treatment with Fingolimod, IFNbeta-1alpha, glatiramer acetate, and dimethyl fumarate drugs. J Pers Med 11(8):721. https:\/\/doi.org\/10.3390\/jpm11080721","DOI":"10.3390\/jpm11080721"},{"issue":"1","key":"4183_CR50","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s13075-021-02664-y","volume":"23","author":"YY Qi","year":"2021","unstructured":"Qi YY, Zhao XY, Liu XR et al (2021) Lupus susceptibility region containing CTLA4 rs17268364 functionally reduces CTLA4 expression by binding EWSR1 and correlates IFN-alpha signature. Arthritis Res Ther 23(1):279. https:\/\/doi.org\/10.1186\/s13075-021-02664-y","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"4183_CR51","doi-asserted-by":"publisher","first-page":"6606","DOI":"10.4049\/jimmunol.165.11.6606","volume":"165","author":"T Kouki","year":"2000","unstructured":"Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ (2000) CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves\u2019 disease. J Immunol 165(11):6606\u20136611. https:\/\/doi.org\/10.4049\/jimmunol.165.11.6606","journal-title":"J Immunol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04183-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04183-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04183-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T11:10:53Z","timestamp":1729595453000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04183-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["4183"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04183-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,23]]},"assertion":[{"value":"6 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the University of Belgrade-Faculty of Medicine (14 March 2021\/No.17\/IV-5).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}